Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Radiology, Mayo Clinic Rochester, Rochester, MN, USA.
J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108084. doi: 10.1016/j.jstrokecerebrovasdis.2024.108084. Epub 2024 Oct 10.
Preventing early aneurysm rebleeding is crucial in the management of aneurysmal subarachnoid hemorrhage (SAH). Lowering systolic blood pressure (SBP) has been proposed as a potential strategy, but the evidence remains inconclusive. This systematic review and meta-analysis aimed to determine if a specific SBP target could reduce the risk of aneurysm rebleeding prior to treatment.
Electronic databases were systematically searched for studies comparing SBP between SAH patients with and without aneurysm rebleeding before surgical treatment. Data on SBP values, patient characteristics, and rebleeding events were extracted. Meta-analyses were performed to pool mean SBP differences and odds ratios (ORs) for rebleeding at different SBP cut-offs.
Ten studies were included in the systematic review. Pooled data from the included studies showed that the mean SBP was higher in the rebleeding group (mean difference 5.89, 95 % CI 1.94 to 9.85). SBP ≤160 mmHg was associated with lower rebleeding risk (OR 0.30, 95 % CI 0.14 to 0.65). However, substantial heterogeneity and limitations in study designs and definitions were noted.
This meta-analysis suggests that SAH patients with rebleeding may present with higher SBP. However, the findings should be interpreted cautiously due to study limitations. Future prospective studies with standardized definitions and comprehensive data collection are needed to elucidate the complex relationship between blood pressure dynamics and rebleeding risk in SAH.
预防动脉瘤再出血对于动脉瘤性蛛网膜下腔出血(SAH)的治疗至关重要。降低收缩压(SBP)已被提议作为一种潜在策略,但证据仍不确定。本系统评价和荟萃分析旨在确定特定的 SBP 目标是否可以降低治疗前动脉瘤再出血的风险。
系统检索电子数据库,比较手术治疗前有和无动脉瘤再出血的 SAH 患者的 SBP。提取 SBP 值、患者特征和再出血事件的数据。进行荟萃分析以汇总不同 SBP 截断值下再出血的平均 SBP 差异和比值比(OR)。
系统评价纳入了 10 项研究。纳入研究的汇总数据显示,再出血组的平均 SBP 较高(平均差异 5.89,95%CI 1.94 至 9.85)。SBP≤160mmHg 与较低的再出血风险相关(OR 0.30,95%CI 0.14 至 0.65)。然而,研究设计和定义存在显著异质性和局限性。
这项荟萃分析表明,再出血的 SAH 患者可能存在更高的 SBP。然而,由于研究局限性,应谨慎解释这些发现。需要未来进行具有标准化定义和全面数据收集的前瞻性研究,以阐明 SAH 中血压动态与再出血风险之间的复杂关系。